Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma, New England Journal of Medicine, vol.333, issue.23, pp.1540-1545, 1995. ,
DOI : 10.1056/NEJM199512073332305
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma, New England Journal of Medicine, vol.335, issue.2, pp.91-97, 1996. ,
DOI : 10.1056/NEJM199607113350204
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION, The Lancet, vol.334, issue.8663, pp.580-585, 1989. ,
DOI : 10.1016/S0140-6736(89)90711-3
Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma, J Clin Oncol, vol.16, pp.1547-1553, 1998. ,
Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood, Exp Hematol, vol.18, pp.442-447, 1990. ,
Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells, J Clin Oncol, vol.14, pp.277-286, 1996. ,
Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation, Blood, vol.98, pp.2059-2064, 2001. ,
Randomized Cross-Over Trial of Progenitor-Cell Mobilization: High-Dose Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor (G-CSF) Versus Granulocyte-Macrophage Colony-Stimulating Factor Plus G-CSF, Journal of Clinical Oncology, vol.18, issue.9, pp.1824-1830, 2000. ,
DOI : 10.1200/JCO.2000.18.9.1824
Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor, Blood, vol.98, issue.5, pp.1289-1297, 2001. ,
DOI : 10.1182/blood.V98.5.1289
Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment, Experimental Hematology, vol.30, issue.5, pp.440-449, 2002. ,
DOI : 10.1016/S0301-472X(02)00788-9
Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts, Bone Marrow Transplantation, vol.28, issue.11, pp.1073-1082, 2001. ,
DOI : 10.1038/sj.bmt.1703270
Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells, Experimental Hematology, vol.29, issue.4, pp.458-470, 2001. ,
DOI : 10.1016/S0301-472X(01)00613-0
Role for granulocyte colonystimulating factor in the generation of human T regulatory type 1 cells Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients, Blood. Exp Hematol, vol.100, issue.28, pp.2562-2571, 2000. ,
Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo, Blood, vol.95, pp.2269-2274, 2000. ,
Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer, Blood, vol.95, pp.2024-2030, 2000. ,
Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden, Immunology, vol.65, pp.87-92, 1988. ,
CD4+CD25+ regulatory T???cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative, European Journal of Immunology, vol.34, issue.2, pp.336-344, 2004. ,
DOI : 10.1002/eji.200324181
Concomitant Tumor Immunity to a Poorly Immunogenic Melanoma Is Prevented by Regulatory T Cells, The Journal of Experimental Medicine, vol.59, issue.6, pp.771-782, 2004. ,
DOI : 10.1038/nature01152
Regulatory T cells and mechanisms of immune system control, Nature Medicine, vol.155, issue.8, pp.801-805, 2004. ,
DOI : 10.1084/JEM.20011288
Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells, Trends in Immunology, vol.25, issue.7, pp.374-380, 2004. ,
DOI : 10.1016/j.it.2004.04.009
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells, International Immunology, vol.16, issue.11, pp.1643-1656, 2004. ,
DOI : 10.1093/intimm/dxh165
CD4+CD25+ Immunoregulatory T Cells, Immunity, vol.16, issue.2, pp.311-323, 2002. ,
DOI : 10.1016/S1074-7613(02)00280-7
Suppressive properties of human CD4+CD25+ regulatory T?cells are dependent on CTLA-4 expression, European Journal of Immunology, vol.542, issue.12, pp.3485-3496, 2004. ,
DOI : 10.1002/eji.200324632
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma, Leukemia, vol.18, pp.1085-1092, 2004. ,
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions, Nature, vol.9, issue.6754, pp.708-712, 1999. ,
DOI : 10.1038/44385
Dynamics of T Lymphocyte Responses: Intermediates, Effectors, and Memory Cells, Science, vol.290, issue.5489, pp.92-97, 2000. ,
DOI : 10.1126/science.290.5489.92
Similarities and differences in CD4+ and CD8+ effector and memory T cell generation, Nature Immunology, vol.4, issue.9, pp.835-842, 2003. ,
DOI : 10.1038/ni969
Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro, Leukemia, vol.14, issue.12, pp.2182-2192, 2000. ,
DOI : 10.1038/sj.leu.2401925
IFN-alpha induces autocrine production of IL-6 in myeloma cell lines, J Immunol, vol.147, pp.4402-4407, 1991. ,
Changes in CD4+ T-Cell Differentiation Phenotype During Structured Treatment Interruption in Patients With Chronic HIV-1 Infection, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.34, issue.5, pp.475-481, 2003. ,
DOI : 10.1097/00126334-200312150-00005
Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions, Blood, vol.102, issue.5, pp.1779-1787, 2003. ,
DOI : 10.1182/blood-2003-02-0420
CD4+CD25high Regulatory Cells in Human Peripheral Blood, The Journal of Immunology, vol.167, issue.3, pp.1245-1253, 2001. ,
DOI : 10.4049/jimmunol.167.3.1245
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide, Blood, vol.105, issue.7, pp.2862-2868, 2005. ,
DOI : 10.1182/blood-2004-06-2410
Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immmunotherapy, Immunological Reviews, vol.152, issue.1, pp.61-72, 1997. ,
DOI : 10.1084/jem.181.3.993
Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics, Blood, vol.98, issue.6, pp.1963-1970, 2001. ,
DOI : 10.1182/blood.V98.6.1963
Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice., Journal of Clinical Investigation, vol.101, issue.2, pp.429-441, 1998. ,
DOI : 10.1172/JCI1348
T cells to the antitumor immune response, The Journal of Experimental Medicine, vol.12, issue.200, pp.1591-1602, 2005. ,
DOI : 10.1126/science.274.5284.94
Lymphocyte and Dendritic Cell Mobilization with Intermediate Doses of Recombinant Human Granulocyte Colony-Stimulating Factor in Healthy Donors, Stem Cells and Development, vol.14, issue.3, pp.310-316, 2005. ,
DOI : 10.1089/scd.2005.14.310
Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Diabetes Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, Nat Med, vol.54, issue.10, pp.78-84, 2004. ,
Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands, Immunity, vol.20, issue.1, pp.107-118, 2004. ,
DOI : 10.1016/S1074-7613(03)00359-5
Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation, Blood, vol.92, pp.1471-1490, 1998. ,
regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization, The Journal of Experimental Medicine, vol.136, issue.5, pp.723-735, 2005. ,
DOI : 10.1016/S1074-7613(00)80195-8
CD4+CD25+ T Regulatory Cells, Immunotherapy of Cancer, and Interleukin-2, Journal of Immunotherapy, vol.28, issue.2, pp.120-128, 2005. ,
DOI : 10.1097/01.cji.0000155049.26787.45
IL-7 and IL-15: therapeutic cytokines for immunodeficiency, Trends in Immunology, vol.26, issue.1, pp.56-64, 2005. ,
DOI : 10.1016/j.it.2004.11.002
regulatory T cells in inflamed synovia, The Journal of Experimental Medicine, vol.25, issue.11, pp.1793-1803, 2005. ,
DOI : 10.1182/blood-2002-08-2408
T cell stimulation and expansion using anti-CD3/CD28 beads, Journal of Immunological Methods, vol.275, issue.1-2, pp.251-255, 2003. ,
DOI : 10.1016/S0022-1759(03)00010-3
Large-Scale Depletion of CD25+ Regulatory T Cells from Patient Leukapheresis Samples, Journal of Immunotherapy, vol.28, issue.4, pp.403-411, 2005. ,
DOI : 10.1097/01.cji.0000170363.22585.5a
The utilization of cytokines in stem cell mobilization strategies, Bone Marrow Transplantation, vol.23, issue.2, pp.13-19, 1999. ,
DOI : 10.1038/sj.bmt.1701669
Stem cell factor in combination, 1999. ,